EVERMIL 10MG TABLET

About

Evermil 10mg Tablet contains Everolimus, a potent immunosuppressive and antineoplastic agent that acts as an inhibitor of the mammalian target of rapamycin (mTOR). The mTOR pathway is a critical regulator of cell growth, proliferation, and survival, and its inhibition by Everolimus leads to a reduction in immune cell activity, thereby preventing organ transplant rejection. In cancer therapy, Everolimus disrupts tumor cell growth and angiogenesis by targeting this same pathway, making it effective against specific malignancies.

This medication is primarily used for the prophylaxis of organ rejection in adult kidney and heart transplant recipients, typically in combination with other immunosuppressive agents. Additionally, it is indicated for the treatment of advanced renal cell carcinoma, progressive neuroendocrine tumors of pancreatic origin, and subependymal giant cell astrocytoma associated with tuberous sclerosis complex. Its dual role in immunosuppression and oncology underscores its therapeutic versatility.

Uses

• Prevention of organ rejection in kidney transplant recipients.
• Treatment of advanced renal cell carcinoma.
• Management of progressive neuroendocrine tumors.
• Therapy for subependymal giant cell astrocytoma.

Directions For Use

Take Evermil 10mg Tablet orally, once daily, at the same time each day, consistently with or without food. Swallow the tablet whole; do not crush, chew, or break it.

Benefits

• Effectively prevents organ transplant rejection.
• Inhibits the growth of certain cancer cells.
• Reduces tumor burden in specific cancers.
• Offers a targeted therapeutic option.
• Improves graft survival in transplant patients.
• Manages symptoms of specific neurological tumors.

Side Effects

• Oral mucositis
• Rash
• Fatigue
• Diarrhea
• Nausea
• Peripheral edema
• Anemia
• Hyperglycemia
• Hyperlipidemia
• Infections (e.g., viral, bacterial)
• Proteinuria
• Non-infectious pneumonitis

Safety Measures

• Alcohol - Avoid alcohol consumption as it may increase the risk of adverse effects or interfere with the drug's metabolism.
• Pregnancy - Evermil is contraindicated during pregnancy due to potential teratogenic effects. Women of childbearing potential must use highly effective contraception.
• Breastfeeding - Breastfeeding is not recommended while on Evermil therapy as the drug may be excreted in breast milk and could harm the nursing infant.
• Liver - Patients with hepatic impairment require careful dose adjustment and close monitoring of drug levels and liver function tests.
• Kidney - Use with caution in patients with renal impairment. Although not primarily renally cleared, kidney function should be monitored, especially in transplant patients.
• Lung - Interstitial lung disease is a serious potential side effect; patients should be monitored for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.